Standout Papers

The use of faecal microbiota transplant as treatment for recurrent or refractory<i>Clostridium difficile... 2018 2026 2020 2023 248
  1. The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines (2018)
    Benjamin H. Mullish, Mohammed Nabil Quraishi et al. Gut

Immediate Impact

1 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut
2025 Standout
Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
2025 Standout
3 intermediate papers

Works of Alaric Colville being referenced

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
2018
The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
2018 Standout

Author Peers

Author Last Decade Papers Cites
Alaric Colville 125 242 77 180 4 325
Jon Reich 164 229 73 160 7 357
Victoria McCune 128 274 82 194 5 339
Chenyang Wang 71 106 45 178 10 336
Deborah Cloney 85 205 58 182 8 332
Sangman M. Kim 105 51 104 129 6 310
Elijah Bogart 64 149 29 264 6 338
Bradley A. Schmidt 77 151 39 190 6 272
Maria Sapnara 154 50 97 120 8 360
Arjit Mohapatra 52 91 20 222 4 364
Leroy E. Cohen 164 153 76 46 7 370

All Works

Loading papers...

Rankless by CCL
2026